HKSE - Delayed Quote HKD

PERFECT MEDICAL (1830.HK)

Compare
2.020
-0.020
(-0.98%)
At close: February 7 at 4:08:07 PM GMT+8
Loading Chart for 1830.HK
DELL
  • Previous Close 2.040
  • Open 2.010
  • Bid 2.000 x --
  • Ask 2.020 x --
  • Day's Range 1.990 - 2.020
  • 52 Week Range 1.980 - 3.400
  • Volume 516,411
  • Avg. Volume 656,486
  • Market Cap (intraday) 2.538B
  • Beta (5Y Monthly) 1.16
  • PE Ratio (TTM) 8.78
  • EPS (TTM) 0.230
  • Earnings Date Nov 29, 2024
  • Forward Dividend & Yield 0.24 (9.05%)
  • Ex-Dividend Date Aug 15, 2024
  • 1y Target Est 3.40

Perfect Medical Health Management Limited, an investment holding company, engages in the provision of medical, aesthetic medical, and beauty and well services in Hong Kong, the People's Republic of China, Macau, Australia, and Singapore. The company offers pain management and hair growth treatments, as well as sleep therapy treatment services under the Goku Spa brand name. It also provides advertising, charitable, and management services; holds trademarks; and rents equipment. The company was formerly known as Perfect Shape Medical Limited and changed its name to Perfect Medical Health Management Limited in June 2021. Perfect Medical Health Management Limited was founded in 2003 and is headquartered in Mong Kok, Hong Kong.

perfectmedical.com

1,273

Full Time Employees

March 31

Fiscal Year Ends

Recent News: 1830.HK

View More

Performance Overview: 1830.HK

Trailing total returns as of 2/7/2025, which may include dividends or other distributions. Benchmark is

.

YTD Return

1830.HK
8.60%
HANG SENG INDEX
5.35%

1-Year Return

1830.HK
31.39%
HANG SENG INDEX
31.41%

3-Year Return

1830.HK
51.19%
HANG SENG INDEX
14.02%

5-Year Return

1830.HK
6.93%
HANG SENG INDEX
22.88%

Compare To: 1830.HK

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 1830.HK

View More

Valuation Measures

As of 2/7/2025
  • Market Cap

    2.54B

  • Enterprise Value

    2.30B

  • Trailing P/E

    8.74

  • Forward P/E

    6.73

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.96

  • Price/Book (mrq)

    5.61

  • Enterprise Value/Revenue

    1.78

  • Enterprise Value/EBITDA

    4.25

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    22.67%

  • Return on Assets (ttm)

    18.65%

  • Return on Equity (ttm)

    55.97%

  • Revenue (ttm)

    1.39B

  • Net Income Avi to Common (ttm)

    315.8M

  • Diluted EPS (ttm)

    0.230

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    567.4M

  • Total Debt/Equity (mrq)

    54.09%

  • Levered Free Cash Flow (ttm)

    363.4M

Research Analysis: 1830.HK

View More

People Also Watch